The latest wave of market euphoria prompts us to take profit and adopt a patient stance. Economic recovery could end up being slow and erratic, and a further round of volatility is possible.
Post-lockdown re-openings have triggered a sharp bounce back in economic activity across many countries, in line with what we had expected for the third stage of the Baa-shaped growth trajectory outlined in our previous Quarterly Outlook. While we take encouragement from the unprecedented ‘anything goes’ fiscal and monetary policy support in developed markets, as well as from efforts to contain the risk of a renewed outbreak, some countries are still struggling to contain the first wave of infections.
To us it seems prudent not to downplay the risk of a slow recovery path or even a second downleg in growth – the fourth stage of ‘Baa’ – as the OECD recently also warned. With virus developments diverging sharply across and even within countries, we favor an increasingly selective approach, especially in emerging markets. An ‘anything goes’ policy response has lifted valuations, but that leaves risk assets pricing in economic outcomes that we believe are more uncertain. After extremes in euphoria in January and risk aversion in March, the latest wave of euphoria into July prompts us to take profits and adopt a patient stance for the next potential wave of volatility.
We continue to think V, W, U and L remain inadequate descriptors for the growth trajectory. To be clear, we do not expect a relapse of April 2020 proportions. But we think that virus uncertainty, the existing pre-Covid debt overhangs now exacerbated by the H1 2020 revenue decline and the collateral damage to spending from bankruptcies and job shedding, will dampen the outlook more than many suspect. The V-shaped case rests on the idea that the recession is purely exogenous. Yet in our analysis there were huge imbalances in private sector debt coming into this, be it in US corporates, Chinese credit, or income inequality. Threats to trade are evident too. The US expansion was the longest in history. Per JK Galbraith and Irving Fisher, these traits all have the hallmarks of initial conditions heading into 1929.
We prefer to place the pandemic in its cyclical context and be humble about filling in the blanks of the non-mathematical part of the growth outlook. To us, this has clear market ramifications where only the rosier scenario is currently being priced in.
Fiscal and monetary policymakers around the globe have responded to the crisis with, it seems, an ‘anything goes’ approach, in their efforts to prevent the initial shock from morphing into a protracted aggregate demand slump. We expect policy intervention to remain in place, with the emphasis now shifting to the fiscal.
For the ultimate impact of the crisis, it matters a lot whether or not a country is able to orchestrate a fiscal cushion to bridge the gap in income and kickstart the economy. Here there are key differences between developed and emerging market countries, and also divergences within emerging markets. Those countries that were already suffering from waning investor trust going into the crisis will probably experience the most difficulties in financing a fiscal impulse to deal with the economic impact of the virus.
Governments face tough choices and policy dilemmas, as they have throughout 2020. As the south and west of the US is now experiencing, and as China found in late January, the dilemma is: do you reopen the economy to save jobs and businesses and seek to avert 1930s outcomes, or do you focus on the virus and prioritize health? The risk with the first approach is that you might initially win the battle on the economy, but then lose the war on the virus in any case, and thus the economy, too.
So, with fiscal policy, it is all very well to extend bridges, SME lending and furlough schemes. But by making them semi-permanent while removing incentives, the usually helpful free market Schumpeterian forces and reallocation of resources across the economy will be blocked, leading to permanently lower growth amid higher government debt overhangs. Some tapering of support seems advisable, but there are no easy answers.
Looking ahead, we believe central banks will remain instrumental in allowing the huge fiscal loosening to continue, while aiming to keep sovereign rates curves in lockdown. For the Fed, this could eventually imply increasing the maturity of purchases and/or reaccelerating the purchase pace – or even embracing some form of yield curve control in due course. For the ECB, a further increase in the size of PEPP beckons around the turn of the year.
We have had the ‘anything goes’ period of policy already. But just as Lady Gaga offered her own version of the Cole Porter original, for policy to be effective from here we will need a remix.
This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.
Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.